Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Several organizations have developed frameworks to systematically assess the value of new drugs. These organizations include the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), the Institute for Clinical and Economic Review (ICER), and the National Com...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Value in health Ročník 20; číslo 2; s. 200 - 205
Hlavní autoři:	Bentley, Tanya G.K., Cohen, Joshua T., Elkin, Elena B., Huynh, Julie, Mukherjea, Arnab, Neville, Thanh H., Mei, Matthew, Copher, Ronda, Knoth, Russell, Popescu, Ioana, Lee, Jackie, Zambrano, Jenelle M., Broder, Michael S.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.02.2017 Elsevier Science Ltd
Témata:	Antineoplastic Agents - standards Cancer Confidence intervals Convergent validity Decision making Decision Support Techniques Drugs Evaluation Feedback Health care inter-rater reliability Internal Medicine Lung cancer Medical decision making Medical Oncology Oncology Pilot Projects Reliability Reproducibility of Results Sensitivity analysis Validity Value value frameworks Value-Based Purchasing convergent validity value frameworks oncology inter-rater reliability
ISSN:	1098-3015, 1524-4733, 1524-4733
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!